These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 34600888)

  • 1. Exosome-mediated mRNA delivery in vivo is safe and can be used to induce SARS-CoV-2 immunity.
    Tsai SJ; Atai NA; Cacciottolo M; Nice J; Salehi A; Guo C; Sedgwick A; Kanagavelu S; Gould SJ
    J Biol Chem; 2021 Nov; 297(5):101266. PubMed ID: 34600888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosome-Based Multivalent Vaccine: Achieving Potent Immunization, Broadened Reactivity, and Strong T-Cell Responses with Nanograms of Proteins.
    Cacciottolo M; Nice JB; Li Y; LeClaire MJ; Twaddle R; Mora CL; Adachi SY; Chin ER; Young M; Angeles J; Elliott K; Sun M
    Microbiol Spectr; 2023 Jun; 11(3):e0050323. PubMed ID: 37093009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivery and Expression of mRNA in the Secondary Lymphoid Organs Drive Immune Responses to Lipid Nanoparticle-mRNA Vaccines after Intramuscular Injection.
    Takanashi A; Pouton CW; Al-Wassiti H
    Mol Pharm; 2023 Aug; 20(8):3876-3885. PubMed ID: 37491979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs.
    Tombácz I; Laczkó D; Shahnawaz H; Muramatsu H; Natesan A; Yadegari A; Papp TE; Alameh MG; Shuvaev V; Mui BL; Tam YK; Muzykantov V; Pardi N; Weissman D; Parhiz H
    Mol Ther; 2021 Nov; 29(11):3293-3304. PubMed ID: 34091054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid nanoparticle formulations for optimal RNA-based topical delivery to murine airways.
    Tam A; Kulkarni J; An K; Li L; Dorscheid DR; Singhera GK; Bernatchez P; Reid G; Chan K; Witzigmann D; Cullis PR; Sin DD; Lim CJ
    Eur J Pharm Sci; 2022 Sep; 176():106234. PubMed ID: 35688311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanograms of SARS-CoV-2 spike protein delivered by exosomes induce potent neutralization of both delta and omicron variants.
    Cacciottolo M; Li Y; Nice JB; LeClaire MJ; Twaddle R; Mora CL; Adachi SY; Young M; Angeles J; Elliott K; Sun M
    PLoS One; 2023; 18(8):e0290046. PubMed ID: 37607200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosomes in COVID-19 infection: Focus on role in diagnosis, pathogenesis, immunity, and clinical trials.
    Aljuhani A; Albalawi O; Albalawi R; Alsalama R; Alatawi S; Altemani R; Abdel-Maksoud MS; Elsherbiny N
    Cell Biol Int; 2023 Jun; 47(6):1049-1067. PubMed ID: 36934395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microfluidic production of mRNA-loaded lipid nanoparticles for vaccine applications.
    Lopes C; Cristóvão J; Silvério V; Lino PR; Fonte P
    Expert Opin Drug Deliv; 2022 Oct; 19(10):1381-1395. PubMed ID: 36223174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of SARS-CoV-2 hFc-Conjugated Receptor-Binding Domain mRNA Vaccine Delivered
    Elia U; Ramishetti S; Rosenfeld R; Dammes N; Bar-Haim E; Naidu GS; Makdasi E; Yahalom-Ronen Y; Tamir H; Paran N; Cohen O; Peer D
    ACS Nano; 2021 Jun; 15(6):9627-9637. PubMed ID: 33480671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice.
    Laczkó D; Hogan MJ; Toulmin SA; Hicks P; Lederer K; Gaudette BT; Castaño D; Amanat F; Muramatsu H; Oguin TH; Ojha A; Zhang L; Mu Z; Parks R; Manzoni TB; Roper B; Strohmeier S; Tombácz I; Arwood L; Nachbagauer R; Karikó K; Greenhouse J; Pessaint L; Porto M; Putman-Taylor T; Strasbaugh A; Campbell TA; Lin PJC; Tam YK; Sempowski GD; Farzan M; Choe H; Saunders KO; Haynes BF; Andersen H; Eisenlohr LC; Weissman D; Krammer F; Bates P; Allman D; Locci M; Pardi N
    Immunity; 2020 Oct; 53(4):724-732.e7. PubMed ID: 32783919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developing Biodegradable Lipid Nanoparticles for Intracellular mRNA Delivery and Genome Editing.
    Qiu M; Li Y; Bloomer H; Xu Q
    Acc Chem Res; 2021 Nov; 54(21):4001-4011. PubMed ID: 34668716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evaluation of novel oral vaccines based on self-amplifying RNA lipid nanparticles (saRNA LNPs), saRNA transfected Lactobacillus plantarum LNPs, and saRNA transfected Lactobacillus plantarum to neutralize SARS-CoV-2 variants alpha and delta.
    Keikha R; Hashemi-Shahri SM; Jebali A
    Sci Rep; 2021 Oct; 11(1):21308. PubMed ID: 34716391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme-Catalyzed One-Step Synthesis of Ionizable Cationic Lipids for Lipid Nanoparticle-Based mRNA COVID-19 Vaccines.
    Li Z; Zhang XQ; Ho W; Li F; Gao M; Bai X; Xu X
    ACS Nano; 2022 Nov; 16(11):18936-18950. PubMed ID: 36269150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-throughput in vivo screen of functional mRNA delivery identifies nanoparticles for endothelial cell gene editing.
    Sago CD; Lokugamage MP; Paunovska K; Vanover DA; Monaco CM; Shah NN; Gamboa Castro M; Anderson SE; Rudoltz TG; Lando GN; Munnilal Tiwari P; Kirschman JL; Willett N; Jang YC; Santangelo PJ; Bryksin AV; Dahlman JE
    Proc Natl Acad Sci U S A; 2018 Oct; 115(42):E9944-E9952. PubMed ID: 30275336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomes for mRNA delivery: a novel biotherapeutic strategy with hurdles and hope.
    Aslan C; Kiaie SH; Zolbanin NM; Lotfinejad P; Ramezani R; Kashanchi F; Jafari R
    BMC Biotechnol; 2021 Mar; 21(1):20. PubMed ID: 33691652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STING Agonist-Derived LNP-mRNA Vaccine Enhances Protective Immunity Against SARS-CoV-2.
    Zhang Y; Yan J; Hou X; Wang C; Kang DD; Xue Y; Du S; Deng B; McComb DW; Liu SL; Zhong Y; Dong Y
    Nano Lett; 2023 Apr; 23(7):2593-2600. PubMed ID: 36942873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secreted Expression of mRNA-Encoded Truncated ACE2 Variants for SARS-CoV-2 via Lipid-Like Nanoassemblies.
    Li M; Li S; Huang Y; Chen H; Zhang S; Zhang Z; Wu W; Zeng X; Zhou B; Li B
    Adv Mater; 2021 Aug; 33(34):e2101707. PubMed ID: 34278613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid Nanoparticles Deliver the Therapeutic VEGFA mRNA In Vitro and In Vivo and Transform Extracellular Vesicles for Their Functional Extensions.
    Nawaz M; Heydarkhan-Hagvall S; Tangruksa B; González-King Garibotti H; Jing Y; Maugeri M; Kohl F; Hultin L; Reyahi A; Camponeschi A; Kull B; Christoffersson J; Grimsholm O; Jennbacken K; Sundqvist M; Wiseman J; Bidar AW; Lindfors L; Synnergren J; Valadi H
    Adv Sci (Weinh); 2023 Apr; 10(12):e2206187. PubMed ID: 36806740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes.
    Pardi N; Tuyishime S; Muramatsu H; Kariko K; Mui BL; Tam YK; Madden TD; Hope MJ; Weissman D
    J Control Release; 2015 Nov; 217():345-51. PubMed ID: 26264835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid Nanoparticle Packaging Is an Effective and Nontoxic mRNA Delivery Platform in Embryonic Zebrafish.
    Patton C; Farr GH; An D; Martini PGV; Maves L
    Zebrafish; 2018 Jun; 15(3):217-227. PubMed ID: 29369745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.